Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL20564403

CC(C)CC(NC(=O)c1ccc(NCc2c[nH]cn2)cc1-c1cccc2ccccc12)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FNTA P49354 15/20 0.71
PGGT1B P53609 14/20 0.71
FNTB P49356 13/20 0.71
TDP1 Q9NUW8 1/20 0.50
BCL2L1 Q07817 1/20 0.42
NTSR1 P30989 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1396830 1.00 FNTA (0.71) FNTAPGGT1BFNTBTDP1BCL2L1
Trifluoroacetic Acid SCHEMBL31561401 1.00 FNTA (0.71) FNTAPGGT1BFNTBTDP1BCL2L1
Trifluoroacetic Acid SCHEMBL21933140 1.00 FNTA (0.71) FNTAPGGT1BFNTBTDP1BCL2L1
SCHEMBL4280385 0.95 FNTA (0.78) FNTAPGGT1BFNTBTDP1BCL2L1
SCHEMBL20564402 0.90 FNTA (0.61) FNTAPGGT1BFNTBTDP1BCL2L1
SCHEMBL10018886 0.88 FNTA (0.66) FNTAPGGT1BFNTBTDP1
Trifluoroacetic Acid SCHEMBL16112378 0.85 FNTA (0.91) FNTAPGGT1BFNTBTDP1BCL2L1
SCHEMBL7608404 0.85 FNTA (0.71) FNTAPGGT1BFNTB
SCHEMBL16136628 0.85 FNTA (0.71) FNTAPGGT1BFNTB
SCHEMBL6775184 0.85 FNTA (0.69) FNTAPGGT1BFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200147047-A1 Methods of Treating Resistant Cancers UNIVERSITY OF BALTIMORE, MARYLAND (US) 2020-05-14 US claimed
WO-2018213748-A1 METHODS OF TREATING RESISTANT CANCERS UNIVERSITY OF MARYLAND, BALTIMORE (US) 2018-11-22 WO claimed
WO-2018213748-A1 METHODS OF TREATING RESISTANT CANCERS UNIVERSITY OF MARYLAND, BALTIMORE (US) 2018-11-22 WO disclosed